SCHEMBL26338293

SCHEMBL26338293

c1ccc(-c2ccc(N(c3cccc(-c4ccc5c(c4)c(-c4ccccc4)c(-c4ccccc4)c4ccccc45)c3)c3ccccc3-c3ccccc3)c(-c3ccccc3)c2)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 1/20 0.32
▸ HSD17B2 P37059 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ APAF1 O14727 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ XBP1 P17861 1/20 0.31
▸ PTBP1 P26599 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ GALK1 P51570 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ SMAD3 P84022 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26339131 0.99 HSD17B1 (0.32) HSD17B1HSD17B2MEN1APAF1NPC1
SCHEMBL26338294 0.96 HSD17B1 (0.34) HSD17B1HSD17B2MEN1APAF1NPC1
SCHEMBL26339124 0.95 IMPDH2 (0.32) HSD17B1HSD17B2THRBIMPDH2ENPP1
SCHEMBL26338377 0.95 ENPP1 (0.33) HSD17B1HSD17B2THRBIMPDH2ENPP1
SCHEMBL26339179 0.94 MEN1 (0.32) HSD17B1HSD17B2MEN1APAF1NPC1
SCHEMBL26338253 0.94 HSD17B1 (0.34) HSD17B1HSD17B2MEN1APAF1NPC1
SCHEMBL26338249 0.94 IMPDH2 (0.33) HSD17B1HSD17B2MEN1APAF1NPC1
SCHEMBL26340730 0.92 MEN1 (0.33) HSD17B1HSD17B2MEN1APAF1NPC1
SCHEMBL26336604 0.92 MEN1 (0.33) HSD17B1HSD17B2MEN1APAF1NPC1
SCHEMBL26338296 0.92 HSD17B1 (0.33) HSD17B1HSD17B2IMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE LEF1, ELAVL1, PIEZO1 HSD17B1 2697/4885HSD17B2 2994/4885MEN1 201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback